Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Biochim Biophys Acta. 2016 Aug 4;1866(2):151–162. doi: 10.1016/j.bbcan.2016.08.001

Figure 6. Lonidamine (LND) alters TCA cycle intermediates.

Figure 6

LND treatment (150 μM) in DB-1 melanoma cells increases the intracellular levels of lactate, α-ketoglutarate and succinate with concurrent reduction in the levels of citrate, fumarate and malate. Part of this research was originally published in J Biol Chem (52) and modified in the current review manuscript.